|
Market Closed -
NYSE
16:00:02 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 178.69 USD | +1.33% |
|
+0.12% | +57.28% |
| 09-14 | BofA Adjusts Price Target on DaVita to $180 From $170 | MT |
| 08-25 | Davita Inc. Announces New Value-Based Partnership with Humana Inc. to Expand Care for Patients with Chronic Kidney Disease | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Healthcare Facilities & Services
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 11.4B | |||||
| 111B | |||||
| 92.38B | |||||
| 59.15B | - | ||||
| 27.66B | |||||
| 25.75B |
- Stock Market
- Stocks
- DVA Stock
- Charts DaVita Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
